News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

UK Lawmakers Criticizes The Government For Spending $702 Million On Roche (RHHBY)'s Tamiflu When Some Researchers Doubt The Medicine's True Efficacy


1/3/2014 7:14:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

British lawmakers on Friday criticised government spending of 424 million pounds ($702 million) to stockpile Roche's medicine Tamiflu, saying doubts about the drug's effectiveness suggest it may not be money well spent. Parliament's influential Public Accounts Committee (PAC) said it was "surprised and concerned" to discover that information on methods and results of clinical trials of such prescribed drugs "is routinely withheld", and said there was a "lack of consensus over how well Tamiflu ... actually works". "The case for stockpiling antiviral medicines at the current level is based on judgment rather than on evidence of their effectiveness during an influenza pandemic," said Richard Bacon, a leading member of the committee.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES